Literature DB >> 23919338

Diabetic ketoacidosis secondary to L-asparaginase in acute lymphoblastic leukaemia.

G Gifford1, S Milliken, J Greenfield.   

Abstract

We describe a case of severe hyperglycaemia resulting in diabetic ketoacidosis secondary to L-asparaginase. There are few reports of this potentially life-threatening complication, particularly in the English literature. Awareness and recognition of this preventable and manageable problem will improve safe delivery of this anti-leukaemic drug.
© 2013 The Authors; Internal Medicine Journal © 2013 Royal Australasian College of Physicians.

Entities:  

Keywords:  L-asparaginase; diabetes; diabetic ketoacidosis; hyperglycaemia; insulin; leukaemia

Mesh:

Substances:

Year:  2013        PMID: 23919338     DOI: 10.1111/imj.12216

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  4 in total

Review 1.  Long-Term Health Effects of Curative Therapies on Heart, Lungs, and Kidneys for Individuals with Sickle Cell Disease Compared to Those with Hematologic Malignancies.

Authors:  Courtney D Fitzhugh; Emmanuel J Volanakis; Ombeni Idassi; Josh A Duberman; Michael R DeBaun; Debra L Friedman
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

2.  Characteristics of chemotherapy-induced diabetes mellitus in acute lymphoblastic leukemia patients.

Authors:  Shan-Shan Suo; Chen-Ying Li; Yi Zhang; Jing-Han Wang; Yin-Jun Lou; Wen-Juan Yu; Jie Jin
Journal:  J Zhejiang Univ Sci B       Date:  2020 Sept.       Impact factor: 3.066

3.  Diabetic ketoacidosis following PEG-asparaginase therapy

Authors:  Miriam Hinaa Ahmad; Ismat Shafiq
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-10-31

4.  Concurrent diabetic ketoacidosis and pancreatitis in Paediatric acute lymphoblastic leukemia receiving L-asparaginase.

Authors:  Patel Zeeshan Jameel; Sham Lohiya; Amol Dongre; Sachin Damke; Bhavana B Lakhkar
Journal:  BMC Pediatr       Date:  2020-05-18       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.